Exco InTouch Set For Further Growth And Expansion Into Healthcare Markets Through Recent £3.2 Million Investment Round

Use of mobile ePRO set for significant scale-up in 2015

29 January 2015 – Exco InTouch, the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, is pleased to announce that after a successful year it has earmarked capital from the £3.2 million raised from the company’s latest investment round led by Albion ventures, to fund its further growth and expansion into healthcare markets in 2015.

The company is set to build on its 2014 achievements which have set it on a course for further growth and new market entry in 2015. Last year saw increased uptake of mobile ePRO, a trend that is set to continue to rise this year, and the successful launch into the UK National Health Service (NHS) of the “Me&MyCOPD” mHealth Program - an initiative made available through the joint collaboration between Exco InTouch and AstraZeneca. Moreover, Exco InTouch’s delivery of public-facing applications on all three major mobile operating platforms (iOS, Android and Windows8), and its emergence as the only eCOA (Electronic Outcomes Assessment) and ePRO (Electronic Patient Reported Outcomes) provider to comply with the data privacy and security regulations including Safe Harbor, EU data Protection and HIPAA (Health Insurance Portability and Accountability Act), has further marked the company out as a forward looking, industry innovator.

Exco InTouch’s mobile ePRO services are set for substantial scale up in 2015, with the technology firmly established and recognized as safe, secure and cost-effective, offering the flexibility to use devices that meet the required functionality. In addition, the use of technology that patients are familiar with, which is a capability built into the mobile ePRO solutions offered by the company, as well as providing messaging and information that keeps patients accurately informed and up to date with study requirements as standard ePRO features, are set to further strengthen the company’s position as a leading provider of patient engagement solutions.

Expansion into the healthcare market - with emphasis on the UK NHS - utilizing funds from the investment round, is the next logical step forward for Exco InTouch, building on the company’s success in 2014 in deploying services into the NHS through the pharmaceutical partnerships that it has established .

Tim Davis, CEO and Founder at Exco InTouch, commented: “We look forward to implementing the next phase of our company’s growth and development strategy with strong confidence, especially as there is such growing demand for our offering across the clinical and healthcare markets. The investment that we continue to attract reflects the success of our company to date and the exciting prospects for the market sectors in which the business operates.”

He continued: “The latest funding will be used for the specific purpose of scaling up and enhancing our platform to meet the increased demand for patient engagement and eCOA whilst also expanding our capabilities as we enter the ‘direct to payer’ market. Exco InTouch has already established itself as a leading provider of mobile healthcare solutions. This rapidly growing sector is being driven by the increasing need to demonstrate actual benefits of medical treatments for regulatory and reimbursement purposes. Consequently, our unique offering leads the market in the use of patients’ own mobile devices, reducing the cost for customers and improving user compliance”.

Dr Neil Rotherham, Executive Chairman commented: “The application of mobile and digital technologies in the healthcare space is already having a transformational impact. Indeed, we are only at the beginning of a process which will see technology play a critically important role in many aspects of health and wellness. Exco InTouch is very well placed to play a leading role in this transition to technology enabled healthcare, having already developed robust solutions that meet exacting regulatory and validation requirements for services being used directly by patients. The latest funding will allow our company to grow both the scale and breadth of its solutions, enabling larger patient populations to be served with richer functional content.”

He continued: “Our aim it provide services that make a genuine and positive difference to outcomes, whether this is in the broader healthcare sector or within the clinical development environment.”

About Exco InTouch

Exco InTouch is the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers. Using a combination of software and services, Exco InTouch solutions provide simple, secure channels of communication; facilitating the collection of quality data and improving outcomes for sponsors, clinical research organizations, sites and patients.

Working across clinical and late phase trials and mHealth programs, Exco InTouch’s device independent approach enables involvement which integrates into daily life - resulting in motivated and compliant patients, reducing costs associated with withdrawals from trials and improving overall program results.

Since 2004, Exco InTouch has engaged with over 900,000 subjects across 88 countries, over 17,500 hospitals and clinics, in 70 languages. 16 of the top 20 pharmaceutical companies have deployed our trusted applications in the knowledge that data is secure and protected, in line with global regulatory and data protection requirements.

Help employers find you! Check out all the jobs and post your resume.

Back to news